Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges

Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges

The promise of human induced pluripotent stem cells (iPSCs) lies in their ability to serve as a starting material for autologous, or patient-specific, stem cell–based therapies. Since the first publications describing the generation of iPSCs from human tissue in 2007, a Phase I/IIa clinical trial te...

Full description

Bibliographic Details
Main Authors: Aivio, S. (Author), Madrid, M. (Author), Saklayen, N. (Author), Sumen, C. (Author)
Format: Article
Language:English
Published: Blackwell Publishing Inc. 2021
Subjects:
age related macular degeneration
alopecia
Article
autologous
autologous stem cell transplantation
automation
biological therapy
Cell- and Tissue-Based Therapy
cell therapies
cell therapy
clinical outcome
dopaminergic nerve cell
epidermolysis bullosa dystrophica
human
Humans
immunosuppressive treatment
induced pluripotent stem cell
Induced Pluripotent Stem Cells
induced pluripotent stem cells (iPSCs)
keratinocyte
muscle stem cell
muscular dystrophy
neural crest cell
nonhuman
nuclear reprogramming
papillary dermis
Parkinson disease
patient safety
photoreceptor cell
practice guideline
priority journal
quality control
regenerative medicine
retina degeneration
retina pigment cell
somatic cell
stem cell transplantation
Stem Cell Transplantation
thrombocyte
thrombocytopenia
treatment indication
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items